News
Eisai Begins Construction of Its New Injection/Research building at Kawashima Industrial Park in Japan
Eisai Co., Ltd. announced that, as part of one strategic investment towards the realization of its medium-term business plan “EWAY2025”, it has conducted the...
News
Rentschler Biopharma and Leukocare extend service offering with joint U.S. site
Rentschler Biopharma SE, a leading global contract development and manufacturing organization (CDMO) for biopharmaceuticals, and Leukocare AG, a German biotechnology company specialized in the...
Clinical Trials
CureVac Expands CVnCoV COVID-19 Vaccine Candidate Clinical Trial Analyses to Include Phase 2b/3 Variant Specification
CureVac N.V., a global biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA), announced plans to expand and...
Drug Research
Evotec and Takeda enter strategic RNA targeting drug discovery and development alliance
Evotec SE announced that the Company has entered into a multi-RNA target alliance with Takeda Pharmaceutical Company Limited (“Takeda”) with the goal to discover...
News
Thermo Fisher Scientific Collaborates with Protein Metrics to Optimize Mass Spectrometry Data Analysis for Biopharmaceutical and Proteomics Applicatio
Thermo Fisher Scientific, the world leader in serving science, and Protein Metrics, a developer of world-class software tools for protein characterization, have entered into...
News
Two-month long CPhI Japan Connect to meet demand for pharma partnering in Japan
The Japanese pharmaceutical market is preparing for renewed international growth and partnering. In response, CPhI Japan has opened a two-month long virtual event to...
News
Vibalogics boosts U.S. team with expert senior hires ahead of facility launch
Vibalogics, a global contract development and manufacturing organization (CDMO) specializing in the production of virotherapy products, has strengthened its North American team with new...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read